Lv27
156 积分 2023-12-20 加入
Long-Term Results of the International Adjuvant Lung Cancer Trial Evaluating Adjuvant Cisplatin-Based Chemotherapy in Resected Lung Cancer
7小时前
已关闭
Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial
11小时前
已完结
Immune checkpoint inhibitors as neoadjuvant therapy for resectable non-small cell lung cancer: a systematic review and network meta-analysis
21小时前
已完结
Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial
6天前
已完结
Lessons from neoadjuvant immunotherapy in melanoma: understanding antitumour immunity and tumour escape
17天前
已完结
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
23天前
已完结
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
23天前
已完结
Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Multiple Myeloma
23天前
已完结
Belantamab mafodotin plus bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): updated overall survival analysis from a global, randomised, open-label, phase 3 trial
23天前
已完结
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
23天前
已完结
皖公网安备34019202002308
